JI
Congress trade
Sen. James Inhofe (R-OK) sold $15K-$50K of Celgene Corporation (CELG) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Celgene Corporation (CELG) stock worth $15K-$50K in a STOCK Act filing on Dec 12, 2018.
The trade happened on Nov 16, 2018, 26 days before it was made public.
- Traded
- Nov 16, 2018
- Disclosed
- Dec 12, 2018
- Filing delay
- 26 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.